In This Section

SU2C Innovative Research Grants

The Stand Up To Cancer (SU2C) Innovative Research Grants Program is an effort to support the next generation of cancer research leaders in their quest to conquer cancer. It was established in honor of the late Judah Folkman, MD, to recognize him as one of the great innovators in cancer research, an outstanding teacher of young investigators, and an early contributor to the SU2C project.

The 2017 SU2C Innovative Research Grants are focused on immuno-oncology in a program funded by a grant from Bristol-Myers Squibb (BMS).

Meet the Active SU2C Innovative Research Grantees

David M. Barrett, MD, PhD. Rescuing T-cell function for immunotherapy of pediatric malignancies

Gregory L. Beatty, MD, PhD. Targeting the pro-metastatic niche in the liver for cancer immunotherapy

Michael Farwell, MD. Imaging CAR T Cells with a dual function PET reporter gene

Meenakshi Hegde, MD. Reworking negative receptor signals for improved anti-glioma T-cell therapy

Marcela V. Maus, MD, PhD. Engineering novel engineered cellular therapies for solid tumors

Jennifer V. Wargo, MD, MMSc. Delineating the role of the microbiome in modulating tumor & host immunity

John T. Wilson, PhD. Reprogramming tumor immunogenicity with STING-activating nanoparticles

Updated: December 3, 2020